Chris Whelan
Director of Neuroscience Data Science at J&J. Interested in population proteomics, genetics, neuroscience & biomarker development. 🇮🇪🧠🧬
- I'm delighted to announce that the Pharma Proteomics Project will commence full-scale proteomic profiling of the UK Biobank in 2025. We have selected the Olink Proteomics Explore HT platform and Ultima Genomics UG 100 sequencers for this unprecedented study. www.ukbiobank.ac.uk/learn-more-a...
- We will begin by profiling 300k samples, comprising approximately 250k samples collected at baseline visits and 50k samples taken at various follow-up assessments. We aim to incorporate an additional 250k baseline samples and 50k repeat samples pending additional funding.
- Reposted by Chris WhelanAssociation of polygenic scores for neuropsychiatric traits with self-reported professions based on analysis of 420k individuals from UK Biobank and Million Veteran Program. Look at the 'arts & design' category. Artistic talent comes at a cost--a piece of your mind :)
- Reposted by Chris Whelan[Not loaded yet]
- Reposted by Chris Whelan[Not loaded yet]
